“Rising Concerns About Zoonotic Diseases”
- The animal antimicrobials and antibiotics market is expanding as public health authorities, veterinarians, and producers respond to increasing threats of zoonotic diseases, which can transfer from animals to humans and disrupt both food security and global trade
- For instance, leading companies such as Zoetis and Elanco are actively investing in new antimicrobial and antibiotic formulations to address outbreaks of diseases such as avian influenza and swine fever, and are contributing to global disease surveillance efforts for early detection and containment
- The globalization of the food supply chain and intensification of livestock production have heightened scrutiny on disease control, driving significant R&D investment into broad-spectrum and targeted antimicrobial therapies
- Regulatory organizations and governments are introducing stricter regulations and monitoring, as well as traceability initiatives, to control the use of antibiotics in animal health while simultaneously containing potential zoonotic outbreaks
- Technological advances such as rapid diagnostic tools and digital health monitoring in livestock management are being adopted to enable earlier intervention, limit the spread of infectious disease, and optimize the use of antimicrobials
- Consumer awareness of food safety and responsible antibiotic use continues to influence the market, as large food retailers and processors increasingly demand verification of animal health protocols from their suppliers
